British Journal of Haematology

Cover image for British Journal of Haematology

January 1996

Volume 92, Issue 1

Pages 1–246

  1. Annotation

    1. Top of page
    2. Annotation
    3. SHORT REPORT
    1. Interleukin 2 in the management of acute leukaemia (pages 1–8)

      Robin Foa

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.270834.x

    2. Effects of myeloid cell growth factors on alkaline phosphatase, myeloperoxidase, defensin and granulocyte colony-stimulating factor receptor mRNA expression in haemopoietic cells of normal individuals and myeloid disorders (pages 9–22)

      Toshihisa Tsuruta, Kenzaburo Tani, Miyuki Shimane, Keiya Ozawa, Satoshi Takahashi, Daisuke Tsuchimoto, Keisuke Takahashi, Shigekazu Nagata, Noriharu Sato and Shigetaka Asano

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.299833.x

    3. Carboxy-terminal peptides (C1–24 and C13–24 but not C1–13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin (pages 29–34)

      Isabelle Lebeurier, Nada Basara, Sallouha Aïdoudi, Jean Amiral, Jacques Caen and Zhong Chao Han

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.296828.x

    4. Indications for haemopoietic precursor cell transplants in Europe (pages 35–43)

      A. Gratwohl, J. Hermans, H. Baldomero, A. Tichelli, J. M. Goldman and G. Gahrton

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00292.x

    5. Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma (pages 44–48)

      Henk Lokhorst, Pieter Sonneveld, Pierre Wijermans, Marinus Van Marwijk Kooy, Otger Th. Meuwissen, Rien Van Oers, René Van Der Griend and Adriaan Dekker

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00306.x

    6. Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia (pages 49–54)

      Franco Locatelli, Andrea Pession, Patrizia Comoli, Federico Bonetti, Giovanna Giorgiani, Marco Zecca, Rosa Maria Taibi, Maria Elisa Mongini, Franco Ambroselli, Piero De Stefano, Francesca Severi and Guido Paolucci

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00276.x

    7. Efficacy of recombinant interferon-alpha (rIFN-α) in polycythaemia vera: a study of 17 patients and an analysis of published data (pages 55–59)

      P. C. Taylor, G. Dolan, J-P. Ng, B. Paul, R. Collin and J. T. Reilly

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00303.x

    8. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders (pages 60–66)

      Yan LI, Gilles Hetet, Jean-Jacques Kiladjian, Claude Gardin, Bernard Grandchamp and Jean Briere

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00297.x

    9. Serum neural cell adhesion molecule in multiple myeloma and other plasma cell disorders (pages 67–70)

      S. R. Smith, B. Auerbach and L. Morgan

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00277.x

    10. Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation (pages 71–76)

      Erika Isaksson, Magnus Björkholm, Göran Holm, Bo Johansson, Bo Nilsson, HÅkan Mellstedt and Anders ÖSterborg

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.294826.x

    11. Ultrastructural changes during adhesion and migration of pre-B lymphoid leukaemia cells within bone marrow stroma (pages 77–87)

      John Hewson, Alessandra Bianchi, Ken Bradstock, Vicki Makrynikola and David Gottlieb

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00291.x

    12. Studies of P-glycoprotein in chronic myelogenous leukaemia patients: expression, activity and correlations with CD34 antigen (pages 88–96)

      A. G. Turkina, A. Yu Baryshnikov, N. P. Sedyakhina, S. V. Folomeshkina, M. A. Sokolova, N. D. Choroshco and A. A. Stavrovskaya

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.273807.x

    13. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro (pages 97–103)

      P. Panayiotidis, D. Jones, K. Ganeshaguru, L. Foroni and A. V. Hoffbrand

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00305.x

    14. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL (pages 104–115)

      James C. S. Chim, Luke A. Coyle, John C. Yaxley, Merrole F. Cole-Sinclair, Paul K. Cannell, Victor A. Hoffbrand and Letizia Foroni

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.289831.x

    15. Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells (pages 116–126)

      Anna Carter, Nuhad Haddad, Ilana Draxler, Ella Israeli, Batya Raz and Jacob M. Rowe

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.272806.x

  2. SHORT REPORT

    1. Top of page
    2. Annotation
    3. SHORT REPORT
    1. The human CD40 gene lies within chromosome 20q deletions associated with myeloid malignancies (pages 127–130)

      Fotios A. Asimakopoulos, Nicholas J. White, Elisabeth P. Nacheva and Anthony R. Green

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.278812.x

    2. Molecular evidence for a common leukaemic progenitor in acute mixed lymphoid and myeloid leukaemia (pages 131–133)

      Seah H. Lim, Dominic Culligan, Steve Couzens, Janet Fisher, Susan John, Peter Pollard, Alan Burnett and Jack Whittaker

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.281821.x

    3. Multiple gastric involvement by myeloid antigen CD13-positive non-secretory plasma cell leukaemia (pages 134–136)

      Akimichi Ohsaka, Naotake Sato, Yasufumi Imai, Shinji Hirai, Yuji Oka, Masahiro Kikuchi and Atsushi Takahashi

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00282.x

    4. A case of ovarian carcinoma with production of granulocyte colony-stimulating factor (pages 137–139)

      Satoko Sudo, Hideto Yamada, Ken Kikuchi, Akihiko Sumie, Yoichiro Yamashita, Norihiko Tumura, Isao Kawaguchi, Seiichiro Fujimoto, Atushi Kato and Jun Yamaguchi

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.274811.x

    5. Glass slide smears are a suitable source for RT-PCR-based analysis of chromosomal aberrations in leukaemias (pages 140–142)

      R. Schoch, S. Jenisch, T. Haferlach, W. Müller-Ruchholtz, W. Gassmann and H. Löffler

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.302841.x

    6. Determinants of haemoglobin level in steady-state homozygous sickle cell disease (pages 143–149)

      Graham Serjeant, Beryl Serjeant, Adrian Stephens, David Roper, Douglas Higgs, Marjorie Beckford, James Cook and Peter Thomas

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.284816.x

    7. Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis (pages 150–154)

      Roberta Guarnone, Esther Centenara, Manuela Zappa, Alberto Zanella and Giovanni Barosi

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00285.x

    8. Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin (pages 155–158)

      Shinji Nakao, Akiyoshi Takami, Naomi Sugimori, Mikio Ueda, Shintaro Shiobara, Tamotsu Matsuda and Hideaki Mizoguchi

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.293825.x

    9. Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM (pages 159–160)

      Gianfranco Meloni and Tullio Meloni

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.275810.x

    10. Motility of rhG-CSF-induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis (pages 161–168)

      Antonio Azzarà, Giovanni Carulli, Angela Rizzuti-Gullaci, Sistina Minnucci, Enrico Capochiani and Fabio Ambrogi

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00295.x

    11. Sodium butyrate delays neutrophil apoptosis: role of protein biosynthesis in neutrophil survival (pages 169–175)

      Rebecca Stringer, C. Hart and Steven Edwards

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00307.x

    12. Identification of early plasma cells in peripheral blood and their clinical significance (pages 184–191)

      Yuka Harada, Michio M. Kawano, Naihui Huang, Maged S. Mahmoud, Igor A. Lisukov, Keiichiro Mihara, Takako Tsujimoto and Atsushi Kuramoto

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.300835.x

    13. Prolonged E-selectin induction by monocytes potentiates the adhesion of flowing neutrophils to cultured endothelial cells (pages 192–199)

      G. E. Rainger, Marie-Paule Wautier, Gerard Nash and Jean-Luc Wautier

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00308.x

    14. The thromboxane mimetic, U-46619, induces the aggregation of fish thrombocytes (pages 200–211)

      Darryl Hill and Andrew Rowley

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.280814.x

    15. Bleeding disorder due to platelet prostaglandin H synthase-1 (PGHS-1) deficiency (pages 212–217)

      Nevenka Matijevic-Aleksic, Peter McPhedran and Kenneth K. Wu

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.279813.x

    16. Cytomegalovirus-induced thrombocytopenia and haemolysis in an immunocompetent adult (pages 218–220)

      Dick Johan van Spronsen and Wim P. M. Breed

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00288.x

    17. A whole blood assay for platelet HPA1 (PLA1) phenotyping applicable to large-scale screening (pages 221–225)

      Hagop Bessos, Shabana Mirza, Adam McGill, Lorna M. Williamson, Ruth Hadfield and William G. Murphy

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00290.x

    18. Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease (pages 226–230)

      Amanda Lee, F. Fowkes, Anna Rattray, Ann Rumley and Gordon Lowe

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00283.x

    19. A novel mutation (Leu817Pro) causing type 2A von Willebrand disease (pages 241–243)

      D. Gemmati, M. L. Serino, S. Moratelli, G. Ballerini, M. Furbetta, B. Lunghi, G. Marchetti and F. Bernardi

      Version of Record online: 14 NOV 2003 | DOI: 10.1046/j.1365-2141.1996.00301.x

    20. Activated protein C sensitivity ratio in pregnant women at delivery (pages 244–246)

      Florence Mathonnet, Philippe DeMazancourt, Brigitte Bastenaire, Mireille Morot, Norbert Benattar, Sylvie BeufÉ, Jeanne-Yvonne Borg and Yves Giudicelli

      Version of Record online: 25 SEP 2012 | DOI: 10.1046/j.1365-2141.1996.00271.x

SEARCH

SEARCH BY CITATION